Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-17

FDA Approved: LARIN FE 1.5/30 — Supplemental Application (Northstar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for LARIN FE 1.5/30, a combined oral contraceptive containing norethindrone acetate/ethinyl estradiol with ferrous fumar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LARIN FE 1.5/30 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for LARIN FE 1.5/30 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)